Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Thompson

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Therapeutic Innovation & Regulatory Science|January 22, 2019
Role of Patients and Parents in Pediatric Drug DevelopmentVivian W L Tsang, Leanne West, Christine Woods, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air PollutionLilian Calderón-Garcidueñas, Partha S Mukherjee, Katharina Waniek, et al.
Molecular Pharmaceutics|March 5, 2014
Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platformYan Xu, Mei Ou, Ed Keough, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City ResidentsLilian Calderón-Garcidueñas, José Avila-Ramírez, Ana Calderón-Garcidueñas, et al.
Circulation. Cardiovascular Interventions|November 30, 2012
A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemiaDouglas W Losordo, Melina R Kibbe, Farrell Mendelsohn, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Therapeutic Innovation & Regulatory Science|January 22, 2019
Role of Patients and Parents in Pediatric Drug DevelopmentVivian W L Tsang, Leanne West, Christine Woods, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air PollutionLilian Calderón-Garcidueñas, Partha S Mukherjee, Katharina Waniek, et al.
Molecular Pharmaceutics|March 5, 2014
Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platformYan Xu, Mei Ou, Ed Keough, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City ResidentsLilian Calderón-Garcidueñas, José Avila-Ramírez, Ana Calderón-Garcidueñas, et al.
Circulation. Cardiovascular Interventions|November 30, 2012
A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemiaDouglas W Losordo, Melina R Kibbe, Farrell Mendelsohn, et al.
Pageof 5